Director, Regional Community Oncology Expert (RCOE) – East

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.

Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

Job Description

We have an exciting opportunity within US Medical Affairs (USMA) Oncology for a Director, Regional Community Oncology Expert (RCOE) – East, supporting Community Oncology strategy and the Community Cancer Collective (CCC) within Gilead . Reporting to the Senior Director, Community Oncology Strategy and Head of the CCC within the USMA Oncology team, the core efforts of this role are responsible for co-developing the Community Oncology strategy, leading CCC efforts in their territory, and supporting the cross-functional field matrix teams.

This role will be remote, but will require travel within their respective territory, to national and regional meetings, as well as headquarters travel for specific meetings as needed.

The key functions of this role will be to represent and consider the unique role of Community Oncology within the US healthcare system with both external and internal stakeholders, including USMA Strategic Evidence & Collaboration (SEC), US Market Access, USMA Patient Access & Quality of Care (PAQ), Medical Affairs Research (MAR), US Public Affairs, US Government Affairs, Clinical Development, Clinical Operations, Real-World Evidence (RWE), Scientific Communications / Publications, Commercial, Medical Governance, Legal, Compliance, and the field-based medical and commercial teams.

The territory for this role encompasses the eastern united states.

Job Responsibilities

Specific responsibilities for this role will include, but are not limited to:

Support the development (in collaboration with the CCC Lead) of strategies and implementation plans to define and address education, research, and Medical Affairs insights and data generation needs within US Community Oncology practices.

Prepare presentation materials and present scientific data at internal meetings and external advisory boards.

Co-create a RWE generation plan in conjunction with key US Community Oncology practices and initiate key RWE studies to support the use of Trodelvy in breast cancer with the potential to expand to other molecules, indications, and disease areas.

Provide medical and scientific leadership and support at key scientific meetings (including society engagement) with US HCPs and patients, with a focus on Community Oncology practices.

Serve as an educational resource and trainer to Gilead colleagues, including the US Medical Science Liaisons (MSLs) / Medical Key Account Liaisons (MKALs), including medical educational activities, grants, and investigator-sponsored/collaborative studies.

Collaborate with Medical Affairs Research (MAR), the Global Review Committee (GRC) / Local Review Committee (LRC) teams, and Clinical Research and Development (R&D) as needed.

Lead the delivery of timely, accurate, and succinct communication of fair-balanced clinical and scientific presentations to Community Oncology healthcare professionals, both proactively and in response to requests for information, consistent with promotional compliance and regulatory requirements.

Participate in the editorial review of all relevant scientific content to ensure strategic alignment and accuracy.

Support data generation activities through:

Critical review of global investigator-sponsored research (ISR) / collaborative, Ph3b, and Ph4 study proposals generated in the US Community Oncology practices.

Review abstracts and/or manuscripts that result from collaborative and RWE studies generated from Community Oncology practices.

Communicate Gilead’s commitment to scientific excellence through research and education in Community Oncology practices.

Collaborate effectively and in a compliant manner with colleagues in other functional areas within Gilead.

Support the development, deployment, and appropriate use of field tools and resources (e.g. slide decks) for the CCC.

Lead and shepherd oncology medical assets (i.e. field resources) through the Medical Review Committee (MRC) process, in consultation with cross-functional Medical Affairs team members.

Specific point of contact for the cross-functional field matrix teams within their territory. Work with the matrix team to create a One Oncology approach to our Community Oncology strategy and execution.

Serves as a CCC resource to the field matrix team and provides training at national and regional levels for medical and commercial colleagues when needed.

Lead CCC projects/studies based on extensive knowledge base, experience and competency, using a degree of autonomy in the preparation and completion of projects and reports, and by establishing relationships with internal and with external contacts as needed.

Select sites for participation in the CCC based upon an objective set of criteria.

Identify and develop relationships with regional and national opinion leaders to support the CCC at Gilead; establish strong relationships with institutional leaders, researchers, and providers in both academic and community settings.

Anticipates complex obstacles and difficulties that may arise in the field and resolves them in a compliant and collaborative manner.

Maintains familiarity with all relevant complex scientific data and commits to continuing education to maintain knowledge base.

Has the ability to work as a member of several teams, such as the MSL and MKAL teams, Key Account Directors (KADs), national accounts, and others.

Lead relationships with vendors and collaborators on the delivery of materials to include, but not limited to, the CCC Playbook, CCC/SEC Newsletter, CCC Dashboard, and medical communications for the preparation of documents for MRC.

Contribute, as appropriate, to the development of Global and Local strategic plans and collaborate effectively and compliantly with colleagues in other functional areas throughout Gilead.

Support CCC efforts and strategic planning for US-based Oncology Societies focused on community engagement in collaboration with the SEC team and other cross-functional leads.

Other activities, as assigned, to support US Medical Affairs strategy development and tactical execution.

Adheres to all applicable pharmaceutical codes, Office of Inspector General (OIG) guidelines, and Gilead policies.

Exhibits Gilead’s core values:

Integrity (Doing What’s Right)

Teamwork (Working Together)

Excellence (Being Your Best)

Accountability (Taking Personal Responsibility)

Inclusion (Encouraging Diversity)

Basic qualifications:

Bachelor's Degree and 12 Years' Experience

OR

Masters' Degree and 10 Years' Experience

OR

PhD/PharmD and 8 years’ experience

Preferred Qualifications:

Advanced medical, scientific or clinical degree (e.g., PhD, MD, PharmD, NP or PA) with 8+ years' experience in the pharmaceutical industry or healthcare setting.

Industry experience in Medical Affai